Eugia US LLC recalls Gentamicin Injection
- Published
- 25 Jun 2025
- Units affected
- 48,000 vials
- Agency
- FDA
- Country
- United States
The hazard
Failed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ, 08520 Vial- NDC 55150-401-01, Carton NDC 55150-401-25
- Brand / company
- Eugia US LLC
- Codes / lots
- Batch 3GT23006, 3GT23007, 3GT23008, Exp Date: November, 30, 2025
- Distribution
- Nationwide in the USA
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 25 Jun 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.